The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Peroxisome Proliferator-Activated Receptor-γ Calls for Activation in Moderation: Lessons from Genetics and Pharmacology
Open accessAbstract
The peroxisome proliferator-activated receptor gamma (PPARgamma) is a prototypical member of the nuclear receptor superfamily and integrates the control of energy, lipid, and glucose homeostasis. PPARgamma can bind a variety of small lipophilic compounds derived from metabolism and nutrition. These ligands, in turn, determine cofactor recruitment to PPARgamma, regulating the transcription of genes in a variety of metabolic pathways. PPARgamma is the main target of the thiazolidinedione class of insulin-sensitizing drugs, which are currently a mainstay of therapy for type 2 diabetes. However, this therapy has a number of side effects. Here, we review the clinical consequences of PPARgamma polymorphisms in humans, as well as several studies in mice using general or tissue-specific knockout techniques. We also discuss the recent pharmacological literature describing a variety of new PPARgamma partial agonists and antagonists, as well as pan-PPAR agonists. The results of these studies have added to the understanding of PPARgamma function, allowing us to hypothesize a general mechanism of PPARgamma action and speculate on future trends in the use of PPARgamma as a target in the treatment of type II diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Fetal and infant growth and impaired glucose tolerance at age 64
Hales, C. N., Barker, D. J., Clark, P. M., Cox, L. J., Fall, C., Osmond, C., & Winter, P. D. (1991) · BMJ · doi:10.1136/bmj.303.6809.1019 · Cited by 2,708
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150
Forman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,088
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro
Rosen, E. D., Sarraf, P., Troy, A. E., Bradwin, G., Moore, K., Milstone, D. S., Spiegelman, B. M., & Mortensen, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80211-7 · Cited by 2,079
Fruebis, J., Tsao, T., Javorschi, S., Ebbets-Reed, D., Erickson, M., Yen, F. T., Bihain, B. E., & Lodish, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041591798 · Cited by 1,985
Roles of PPARs in health and disease
Kersten, S., Desvergne, B., & Wahli, W. (2000) · Nature · doi:10.1038/35013000 · Cited by 1,956
PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
Barak, Y., Nelson, M. C., Ong, E. S., Jones, Y. Z., Ruiz-Lozano, P., Chien, K. R., Koder, A., & Evans, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80209-9 · Cited by 1,956
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81574-3 · Cited by 1,860
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
A transcriptional co-repressor that interacts with nuclear hormone receptors
Chen, J. D., & Evans, R. M. (1995) · Nature · doi:10.1038/377454a0 · Cited by 1,763
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
Spiegelman, B. M. (1998) · Diabetes · doi:10.2337/diabetes.47.4.507 · Cited by 1,730
Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2094 · Cited by 1,659
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,376
Barroso, I., Gurnell, M., Crowley, V. E. F., Agostini, M., Schwabe, J. W., Soos, M. A., Maslen, G. L., Williams, T. D. M., Lewis, H., Schafer, A. J., et al. (1999) · Nature · doi:10.1038/47254 · Cited by 1,368
A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis
Chawla, A., Boisvert, W. A., Lee, C.-H., Laffitte, B. A., Barak, Y., Joseph, S. B., Liao, D., Nagy, L., Edwards, P. A., Curtiss, L. K., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00164-2 · Cited by 1,347
PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance
Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H., Yamauchi, T., Komeda, K., Satoh, S., Nakano, R., Ishii, C., Sugiyama, T., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80210-5 · Cited by 1,342
Deeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L., Kuusisto, J., Laakso, M., Fujimoto, W., & Auwerx, J. (1998) · Nature Genetics · doi:10.1038/3099 · Cited by 1,319
Self-citationPeroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity
Wang, Y.-X., Lee, C.-H., Tiep, S., Yu, R. T., Ham, J., Kang, H., & Evans, R. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00269-1 · Cited by 1,296
The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
Torchia, J., Rose, D. W., Inostroza, J., Kamei, Y., Westin, S., Glass, C. K., & Rosenfeld, M. G. (1997) · Nature · doi:10.1038/42652 · Cited by 1,283
Schoonjans, K., Staels, B., & Auwerx, J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42003-6 · Cited by 1,216
Self-citationDisruption of Adiponectin Causes Insulin Resistance and Neointimal Formation
Kubota, N., Terauchi, Y., Yamauchi, T., Kubota, T., Moroi, M., Matsui, J., Eto, K., Yamashita, T., Kamon, J., Satoh, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200251200 · Cited by 1,208
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
Fajas, L., Auboeuf, D., Raspé, E., Schoonjans, K., Lefebvre, A.-M., Saladin, R., Najib, J., Laville, M., Fruchart, J.-C., Deeb, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18779 · Cited by 1,188
Self-citationPPARγ: a Nuclear Regulator of Metabolism, Differentiation, and Cell Growth
Rosen, E. D., & Spiegelman, B. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100034200 · Cited by 1,175
Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., et al. (2001) · Nature Medicine · doi:10.1038/83348 · Cited by 1,170
Disruption of adiponectin causes insulin resistance and neointimal formation
Froguel, P. (2002) · HAL · Cited by 1,134
Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., & Kliewer, S. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3406 · Cited by 1,110
Transient increase in obese gene expression after food intake or insulin administration
Saladin, R., De Vos, P., Guerre-Millot, M., Leturque, A., Girard, J., Staels, B., & Auwerx, J. (1995) · Nature · doi:10.1038/377527a0 · Cited by 1,093
Self-citationChawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., & Evans, R. M. (2001) · Nature Medicine · doi:10.1038/83336 · Cited by 1,069
Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes
Saltiel, A. R., & Olefsky, J. M. (1996) · Diabetes · doi:10.2337/diab.45.12.1661 · Cited by 1,053
Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ
Hu, E., Kim, J. B., Sarraf, P., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5295.2100 · Cited by 1,050
Oliver, W. R., Shenk, J. L., Snaith, M. R., Russell, C. S., Plunket, K. D., Bodkin, N. L., Lewis, M. C., Winegar, D. A., Sznaidman, M. L., Lambert, M. H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091021198 · Cited by 1,046
Differentiation and reversal of malignant changes in colon cancer through PPARγ
Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C., et al. (1998) · Nature Medicine · doi:10.1038/2030 · Cited by 988
He, W., Barak, Y., Hevener, A., Olson, P., Liao, D., Le, J., Nelson, M., Ong, E., Olefsky, J. M., & Evans, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536828100 · Cited by 976
Role of CBP/P300 in nuclear receptor signalling
Chakravarti, D., LaMorte, V. J., Nelson, M. C., Nakajima, T., Schulman, I. G., Juguilon, H., Montminy, M., & Evans, R. M. (1996) · Nature · doi:10.1038/383099a0 · Cited by 930
Chawla, A., Schwarz, E. J., Dimaculangan, D. D., & Lazar, M. A. (1994) · Endocrinology · doi:10.1210/en.135.2.798 · Cited by 873
Göttlicher, M., Widmark, E., Li, Q., & Gustafsson, J. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4653 · Cited by 857
Li, A. C., Brown, K. K., Silvestre, M. J., Willson, T. M., Palinski, W., & Glass, C. K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10370 · Cited by 833
Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306981100 · Cited by 832
Self-citationDanielian, P. S., White, R., Lees, J. A., & Parker, M. G. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05141.x · Cited by 803
Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus
Inzucchi, S. E., Maggs, D. G., Spollett, G. R., Page, S. L., Rife, F. S., Walton, V., & Shulman, G. I. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381303 · Cited by 794
Life without white fat: a transgenic mouse
Moitra, J., Mason, M. M., Olive, M., Krylov, D., Gavrilova, O., Marcus-Samuels, B., Feigenbaum, L., Lee, E., Aoyama, T., Eckhaus, M., et al. (1998) · Genes & Development · doi:10.1101/gad.12.20.3168 · Cited by 782
Ricote, M., Huang, J., Fajas, L., Li, A., Welch, J., Najib, J., Witztum, J. L., Auwerx, J., Palinski, W., & Glass, C. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7614 · Cited by 721
Self-citationModulation of Insulin Activities by Leptin
Cohen, B., Novick, D., & Rubinstein, M. (1996) · Science · doi:10.1126/science.274.5290.1185 · Cited by 716
Gavrilova, O., Haluzik, M., Matsusue, K., Cutson, J. J., Johnson, L., Dietz, K. R., Nicol, C. J., Vinson, C., Gonzalez, F. J., & Reitman, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300043200 · Cited by 707
Zhu, Y., Qi, C., Korenberg, J. R., Chen, X. N., Noya, D., Rao, M. S., & Reddy, J. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7921 · Cited by 653
Nuclear Receptors and the Control of Metabolism
Francis, G. A., Fayard, E., Picard, F., & Auwerx, J. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142528 · Cited by 636
Self-citationYu, S., Matsusue, K., Kashireddy, P., Cao, W.-Q., Yeldandi, V., Yeldandi, A. V., Rao, M. S., Gonzalez, F. J., & Reddy, J. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210062200 · Cited by 619
PPARγ, the ultimate thrifty gene
Auwerx, J. (1999) · Diabetologia · doi:10.1007/s001250051268 · Cited by 612
Self-citationLefebvre, A.-M., Chen, I., Desreumaux, P., Najib, J., Fruchart, J.-C., Geboes, K., Briggs, M., Heyman, R., & Auwerx, J. (1998) · Nature Medicine · doi:10.1038/2036 · Cited by 611
Self-citationActivators of the nuclear receptor PPARγ enhance colon polyp formation
Saez, E., Tontonoz, P., Nelson, M. C., Alvarez, J. G. A., U, T. M., Baird, S. M., Thomazy, V. A., & Evans, R. M. (1998) · Nature Medicine · doi:10.1038/2042 · Cited by 587
Matsusue, K., Haluzik, M., Lambert, G., Yim, S.-H., Gavrilova, O., Ward, J. M., Brewer, B., Reitman, M. L., & Gonzalez, F. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317223 · Cited by 585
Hong, H., Kohli, K., Garabedian, M. J., & Stallcup, M. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2735 · Cited by 556
Adams, M., Reginato, M. J., Shao, D., Lazar, M. A., & Chatterjee, V. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.5128 · Cited by 549
Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte Differentiation
Ristow, M., Müller-Wieland, D., Pfeiffer, A., Krone, W., & Kahn, C. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391403 · Cited by 545
Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists
Olefsky, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10843 · Cited by 537
Voegel, J. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.507 · Cited by 515
The role of PPAR-γ in macrophage differentiation and cholesterol uptake
Moore, K. J., Rosen, E. D., Fitzgerald, M. L., Randow, F., Andersson, L. P., Altshuler, D., Milstone, D. S., Mortensen, R. M., Spiegelman, B. M., & Freeman, M. W. (2001) · Nature Medicine · doi:10.1038/83328 · Cited by 513
Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer
Sarraf, P., Mueller, E., Smith, W. M., Wright, H. M., Kum, J. B., Aaltonen, L. A., de la Chapelle, A., Spiegelman, B. M., & Eng, C. (1999) · Molecular Cell · doi:10.1016/s1097-2765(01)80012-5 · Cited by 506
Muscle-specific Pparg deletion causes insulin resistance
Hevener, A. L., He, W., Barak, Y., Le, J., Bandyopadhyay, G., Olson, P., Wilkes, J., Evans, R. M., & Olefsky, J. (2003) · Nature Medicine · doi:10.1038/nm956 · Cited by 492
Yen, C.-J., Beamer, B. A., Negri, C., Silver, K., Brown, K. A., Yarnall, D. P., Burns, D. K., Roth, J., & Shuldiner, A. R. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7798 · Cited by 491
Potent Inhibitory Effect of Troglitazone on Carotid Arterial Wall Thickness in Type 2 Diabetes
Minamikawa, J. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.5.1818 · Cited by 461
Camp, H. S., & Tafuri, S. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10811 · Cited by 446
SRC-1 and TIF2 Control Energy Balance between White and Brown Adipose Tissues
Picard, F., Géhin, M., Annicotte, J.-S., Rocchi, S., Champy, M.-F., O'Malley, B. W., Chambon, P., & Auwerx, J. (2002) · Cell · doi:10.1016/s0092-8674(02)01169-8 · Cited by 444
Self-citationIncreasing the Complexity of Coactivation in Nuclear Receptor Signaling
Freedman, L. P. (1999) · Cell · doi:10.1016/s0092-8674(00)80708-4 · Cited by 434
Savage, D. B., Tan, G. D., Acerini, C. L., Jebb, S. A., Agostini, M., Gurnell, M., Williams, R. L., Umpleby, A. M., Thomas, E. L., Bell, J. D., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.4.910 · Cited by 430
Mueller, E., Smith, M., Sarraf, P., Kroll, T., Aiyer, A., Kaufman, D. S., Oh, W., Demetri, G., Figg, W. D., Zhou, X.-P., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180329197 · Cited by 426
Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects
Suter, S. L., Nolan, J. J., Wallace, P., Gumbiner, B., & Olefsky, J. M. (1992) · Diabetes Care · doi:10.2337/diacare.15.2.193 · Cited by 420
Norris, A. W., Chen, L., Fisher, S. J., Szanto, I., Ristow, M., Jozsi, A. C., Hirshman, M. F., Rosen, E. D., Goodyear, L. J., Gonzalez, F. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17305 · Cited by 417
PPARγ AND G LUCOSE H OMEOSTASIS
Picard, F., & Auwerx, J. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.010402.102808 · Cited by 411
Self-citationThe mode of action of thiazolidinediones
Hauner, H. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.249 · Cited by 411
Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency
Miles, P. D. G., Barak, Y., He, W., Evans, R. M., & Olefsky, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8538 · Cited by 400
The effect of insulin on renal sodium metabolism: A review with clinical implications
DeFronzo, R. A. (1981) · Diabetologia · doi:10.1007/bf00252649 · Cited by 391
Hofmann, C. (1994) · Endocrinology · doi:10.1210/en.134.1.264 · Cited by 387
Imai, T., Takakuwa, R., Marchand, S., Dentz, E., Bornert, J.-M., Messaddeq, N., Wendling, O., Mark, M., Desvergne, B., Wahli, W., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400356101 · Cited by 383
Wright, H. M., Clish, C. B., Mikami, T., Hauser, S., Yanagi, K., Hiramatsu, R., Serhan, C. N., & Spiegelman, B. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1873 · Cited by 368
Akiyama, T. E., Sakai, S., Lambert, G., Nicol, C. J., Matsusue, K., Pimprale, S., Lee, Y.-H., Ricote, M., Glass, C. K., Brewer, H. B., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2607-2619.2002 · Cited by 368
the EURO-BLCS Study Group, & Rogers, I. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802316 · Cited by 366
Ye, J.-M., Doyle, P. J., Iglesias, M. A., Watson, D. G., Cooney, G. J., & Kraegen, E. W. (2001) · Diabetes · doi:10.2337/diabetes.50.2.411 · Cited by 343
Way, J. M., Harrington, W. W., Brown, K. K., Gottschalk, W. K., Sundseth, S. S., Mansfield, T. A., Ramachandran, R. K., Willson, T. M., & Kliewer, S. A. (2001) · Endocrinology · doi:10.1210/endo.142.3.8037 · Cited by 338
PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter
Fajas, L., Fruchart, J.-C., & Auwerx, J. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01273-3 · Cited by 336
Self-citationThe Peroxisome Proliferator-Activated Receptor-γ2 Pro12Ala Polymorphism
Stumvoll, M., & Häring, H. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2341 · Cited by 332
Berger, J. P., Petro, A. E., Macnaul, K. L., Kelly, L. J., Zhang, B. B., Richards, K., Elbrecht, A., Johnson, B. A., Zhou, G., Doebber, T. W., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0217 · Cited by 321
Chen, Z., Ishibashi, S., Perrey, S., Osuga, J.-I., Gotoda, T., Kitamine, T., Tamura, Y., Okazaki, H., Yahagi, N., Iizuka, Y., et al. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.3.372 · Cited by 320
Lee, G., Elwood, F., McNally, J., Weiszmann, J., Lindstrom, M., Amaral, K., Nakamura, M., Miao, S., Cao, P., Learned, R. M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200743200 · Cited by 319
A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation
Oberfield, J. L., Collins, J. L., Holmes, C. P., Goreham, D. M., Cooper, J. P., Cobb, J. E., Lenhard, J. M., Hull-Ryde, E. A., Mohr, C. P., Blanchard, S. G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6102 · Cited by 316
Activation of PPARδ alters lipid metabolism in db/db mice
Leibowitz, M. D., Fiévet, C., Hennuyer, N., Peinado-Onsurbe, J., Duez, H., Berger, J., Cullinan, C. A., Sparrow, C. P., Baffic, J., Berger, G. D., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01554-4 · Cited by 308
Self-citationPioglitazone Induces In Vivo Adipocyte Differentiation in the Obese Zucker fa/fa Rat
Haliakon, S., Doaré, L., Foufelle, F., Kergoat, M., Guerre-Millo, M., Berthault, M.-F., Dugail, I., Morin, J., Auwerx, J., & Ferré, P. (1997) · Diabetes · doi:10.2337/diab.46.9.1393 · Cited by 306
Self-citationHenke, B. R., Blanchard, S. G., Brackeen, M. F., Brown, K. K., Cobb, J. E., Collins, J. L., Harrington, Hashim, M. A., Hull-Ryde, E. A., Kaldor, I., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9804127 · Cited by 301
Tamori, Y., Masugi, J., Nishino, N., & Kasuga, M. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2045 · Cited by 294
Beamer, B. A., Yen, C. J., Andersen, R. E., Muller, D., Elahi, D., Cheskin, L. J., Andres, R., Roth, J., & Shuldiner, A. R. (1998) · Diabetes · doi:10.2337/diabetes.47.11.1806 · Cited by 293
Claudel, T., Leibowitz, M. D., Fiévet, C., Tailleux, A., Wagner, B., Repa, J. J., Torpier, G., Lobaccaro, J.-M., Paterniti, J. R., Mangelsdorf, D. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041609298 · Cited by 292
Self-citationLarsen, T. M., Toubro, S., & Astrup, A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.802223 · Cited by 282
Werman, A., Hollenberg, A., Solanes, G., Bjørbæk, C., Vidal-Puig, A. J., & Flier, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20230 · Cited by 282
Zhang, B., Berger, J., Zhou, G., Elbrecht, A., Biswas, S., White-Carrington, S., Szalkowski, D., & Moller, D. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31771 · Cited by 278
APC-dependent suppression of colon carcinogenesis by PPARγ
Girnun, G. D., Smith, W. M., Drori, S., Sarraf, P., Mueller, E., Eng, C., Nambiar, P., Rosenberg, D. W., Bronson, R. T., Edelmann, W., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162480299 · Cited by 277
A Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic Activity
Rocchi, S., Picard, F., Vamecq, J., Gelman, L., Potier, N., Zeyer, D., Dubuquoy, L., Bac, P., Champy, M.-F., Plunket, K. D., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00353-7 · Cited by 272
Self-citationAgarwal, A. K., & Garg, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8290 · Cited by 268
PPARG F388L, a Transactivation-Deficient Mutant, in Familial Partial Lipodystrophy
Hegele, R. A., Cao, H., Frankowski, C., Mathews, S. T., & Leff, T. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3586 · Cited by 264
The Retinoblastoma-Histone Deacetylase 3 Complex Inhibits PPARγ and Adipocyte Differentiation
Fajas, L., Egler, V., Reiter, R., Hansen, J., Kristiansen, K., Debril, M.-B., Miard, S., & Auwerx, J. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00360-x · Cited by 258
Self-citationMori, H., Ikegami, H., Kawaguchi, Y., Seino, S., Yokoi, N., Takeda, J., Inoue, I., Seino, Y., Yasuda, K., Hanafusa, T., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.4.891 · Cited by 238
Schoonjans, K., & Auwerx, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)90002-3 · Cited by 232
Self-citationValve, R. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.10.3708 · Cited by 229
Gelman, L., Zhou, G., Fajas, L., Raspé, E., Fruchart, J.-C., & Auwerx, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7681 · Cited by 223
Self-citationMasugi, J., Tamori, Y., Mori, H., Koike, T., & Kasuga, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2096 · Cited by 216
Rieusset, J., Touri, F., Michalik, L., Escher, P., Desvergne, B., Niesor, E., & Wahli, W. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0036 · Cited by 214
Meirhaeghe, A. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.3.435 · Cited by 207
Masud, S., & Ye, S. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.10.773 · Cited by 205
Genetic Modulation of PPARγ Phosphorylation Regulates Insulin Sensitivity
Rangwala, S. M., Rhoades, B., Shapiro, J. S., Rich, A. S., Kim, J. K., Shulman, G. I., Kaestner, K. H., & Lazar, M. A. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00274-0 · Cited by 204
Buckingham, R. E., Al-Barazanji, K. A., Toseland, C. D. N., Slaughter, M., Connor, S. C., West, A., Bond, B., Turner, N. C., & Clapham, J. C. (1998) · Diabetes · doi:10.2337/diab.47.8.1326 · Cited by 203
Lindi, V. I., Uusitupa, M. I. J., Lindström, J., Louheranta, A., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2581 · Cited by 195
Activation of Nuclear Receptors
Li, Y., Lambert, M. H., & Xu, H. E. (2003) · Structure · doi:10.1016/s0969-2126(03)00133-3 · Cited by 191
Robitaille, J., Després, J., Pérusse, L., & Vohl, M. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00026.x · Cited by 190
Reginato, M. J., Bailey, S. T., Krakow, S. L., Minami, C., Ishii, S., Tanaka, H., & Lazar, M. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32679 · Cited by 185
Iglarz, M., Touyz, R. M., Amiri, F., Lavoie, M.-F., Diep, Q. N., & Schiffrin, E. L. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000047447.67827.cd · Cited by 183
Satoh, H., Tsukamoto, K., Hashimoto, Y., Hashimoto, N., Togo, M., Hara, M., Maekawa, H., Isoo, N., Kimura, S., & Watanabe, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.0126 · Cited by 182
Koutnikova, H., Cock, T.-A., Watanabe, M., Houten, S. M., Champy, M.-F., Dierich, A., & Auwerx, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336090100 · Cited by 182
Self-citationCui, Y., Miyoshi, K., Claudio, E., Siebenlist, U. K., Gonzalez, F. J., Flaws, J., Wagner, K.-U., & Hennighausen, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200186200 · Cited by 180
Wang, Y., Porter, W. W., Suh, N., Honda, T., Gribble, G. W., Leesnitzer, L. M., Plunket, K. D., Mangelsdorf, D. J., Blanchard, S. G., Willson, T. M., et al. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.10.0545 · Cited by 171
Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice
Yamauchi, T., Oike, Y., Kamon, J., Waki, H., Komeda, K., Tsuchida, A., Date, Y., Li, M.-X., Miki, H., Akanuma, Y., et al. (2002) · Nature Genetics · doi:10.1038/ng829 · Cited by 166
In vitro studies on the action of CS-045, a new antidiabetic agent
Ciaraldi, T. P., Gilmore, A., Olefsky, J. M., Goldberg, M., & Heidenreich, K. A. (1990) · Metabolism · doi:10.1016/0026-0495(90)90166-a · Cited by 164
Jiang, W. G., Douglas‐Jones, A., & Mansel, R. E. (2003) · International Journal of Cancer · doi:10.1002/ijc.11302 · Cited by 162
Mancini, F. P., Vaccaro, O., Sabatino, L., Tufano, A., Rivellese, A. A., Riccardi, G., & Colantuoni, V (1999) · Diabetes · doi:10.2337/diabetes.48.7.1466 · Cited by 162
Digenic inheritance of severe insulin resistance in a human pedigree
Savage, D. B., Agostini, M., Barroso, I., Gurnell, M., Luan, J., Meirhaeghe, A., Harding, A.-H., Ihrke, G., Rajanayagam, O., Soos, M. A., et al. (2002) · Nature Genetics · doi:10.1038/ng926 · Cited by 159
The adipocyte specific transcription factor C/EBPalpha modulates human ob gene expression.
Miller, S. G., De Vos, P., Guerre-Millo, M., Wong, K., Hermann, T., Staels, B., Briggs, M. R., & Auwerx, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5507 · Cited by 158
Self-citationSanchez, J. G., Rios, M. S., Pérez, C. F., Laakso, M., & Larrad, M. T. M. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470495 · Cited by 157
Mukherjee, R., Hoener, P. A., Jow, L., Bilakovics, J. M., Klausing, K., Mais, D. E., Faulkner, A. L., Croston, G. E., & Paterniti, J. R. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.9.0528 · Cited by 157
Chen, F., Law, S. W. T., & O’Malley, B. W. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2302 · Cited by 156
Frederiksen, L., Brødbæk, K., Fenger, M., Jørgensen, T., Borch‐Johnsen, K., Madsbad, S., & Urhammer, S. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8732 · Cited by 154
Rosen, E. D., Kulkarni, R., Sarraf, P., Özcan, U., Okada, T., Hsu, C.-H., Eisenman, D., Magnuson, M. A., Gonzalez, F. J., Kahn, C. R., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7222-7229.2003 · Cited by 144
Troglitazone Induces GLUT4 Translocation in L6 Myotubes
Yonemitsu, S., Nishimura, H., Shintani, M., Inoue, R., Yamamoto, Y., Masuzaki, H., Ogawa, Y., Hosoda, K., Inoue, G., Hayashi, T., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1093 · Cited by 143
Lefebvre, A., Peinado‐Onsurbe, J., Leitersdorf, I., Briggs, M. R., Paterniti, J. R., Fruchart, J., Fiévet, C., Auwerx, J. H., & Staels, B. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1756 · Cited by 143
Self-citationDowell, P., Ishmael, J. E., Avram, D., Peterson, V. J., Nevrivy, D. J., & Leid, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15901 · Cited by 139
Norman, R. A., Thompson, D. B., Foroud, T., Garvey, W. T., Bennett, P. H., Bogardus, C., & Ravussin, É. (1997) · PubMed · Cited by 138
The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes
Clément, K., Herçberg, S., Passinge, B., Galan, P., Varroud-Vial, M., Shuldiner, A. R., Beamer, B. A., Charpentier, G., Guy-grand, B., Froguel, P., et al. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801191 · Cited by 135
Mori, Y., Kim-Motoyama, H., Katakura, T., Yasuda, K., Kadowaki, H., Beamer, B. A., Shuldiner, A. R., Akanuma, Y., Yazaki, Y., & Kadowaki, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9421 · Cited by 133
Nicklas, B. J., van Rossum, E. F. C., Berman, D. M., Ryan, A. S., Dennis, K. E., & Shuldiner, A. R. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2172 · Cited by 130
Swarbrick, M. M., Chapman, C., McQuillan, B., Hung, J., Pl, T., & Beilby, J. P. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440277 · Cited by 129
Peroxisome proliferator-activated receptor γ C161→T polymorphism and coronary artery disease
Wang, X. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00256-4 · Cited by 127
Auwerx, J. H. (2002) · Cited by 127
Self-citationDefects of the Chorioallantoic Placenta in Mouse RXRα Null Fetuses
Sapin, V., Dollé, P., Hindelang, C., Kastner, P., & Chambon, P. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8687 · Cited by 126
Doney, A. S. F., Fischer, B., Frew, D., Cumming, A. M., Flavell, D. M., WORLD, M. J., Montgomery, H., Boyle, D. I., Morris, A., & Palmer, C. N. (2002) · BMC Genetics · doi:10.1186/1471-2156-3-21 · Cited by 124
Cha, B. S., Ciaraldi, T. P., Carter, L., Nikoulina, S. E., Mudaliar, S. R. D., Mukherjee, R., Paterniti, J. R., & Henry, R. R. (2001) · Diabetologia · doi:10.1007/s001250051642 · Cited by 112
L-764406 Is a Partial Agonist of Human Peroxisome Proliferator-activated Receptor γ
Elbrecht, A., Chen, Y., Adams, A., Berger, J. P., Griffin, P. R., Klatt, T., Zhang, B., Menke, J. G., Zhou, G., Smith, R. G., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7913 · Cited by 105
Cole, S., Mitchell, B. D., Hsueh, W.-C., et al. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801210 · Cited by 105
Simón, I., Vendrell, J., Gutiérrez, C., Fernández-Real, J., Vendrell, I., Gallart, L., Fontova, R., & Richart, C. (2002) · Hormone Research in Paediatrics · doi:10.1159/000064490 · Cited by 104
Recent Advances in Peroxisome Proliferator-Activated Receptor Science
Shearer, B. G., & Hoekstra, W. J. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033368295 · Cited by 102
Muller, Y. L., Bogardus, C., Beamer, B. A., Shuldiner, A. R., & Baier, L. J. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1864 · Cited by 101
Meirhaeghe, A., Fajas, L., Gouilleux, F., Cottel, D., Helbecque, N., Auwerx, J. H., & Amouyel, P. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000051382.28752.fe · Cited by 101
Self-citationNugent, C., Prins, J. B., Whitehead, J. P., Savage, D. B., Wentworth, J. M., Chatterjee, K., & O’Rahilly, S. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.10.0715 · Cited by 100
The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity
Celi, F. S., & Shuldiner, A. R. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0078-2 · Cited by 99
Lindi, V., Schwab, U., Louheranta, A. M., Laakso, M., Vessby, B. O., Hermansen, K., Storlien, L. H., Riccardi, G., & Rivellese, A. A. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00065-9 · Cited by 97
Camp, H. S., Chaudhry, A., & Leff, T. (2001) · Endocrinology · doi:10.1210/endo.142.7.8254 · Cited by 95
Peroxisome proliferator-activated receptor-γ in macrophage lipid homeostasis
Lee, C., & Evans, R. M. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00668-9 · Cited by 94
Peroxisomal Proliferator-Activated Receptor-γ Upregulates Glucokinase Gene Expression in β-Cells
Kim, H.-I., Cha, J.-Y., Kim, S., Kim, J. W., Roh, K. J., Seong, J. K., Lee, N. T., Choi, K., Kim, K., & Ahn, Y. (2002) · Diabetes · doi:10.2337/diabetes.51.3.676 · Cited by 94
Jaquet, D., Trégouët, D., Godefroy, T., Nicaud, V., Chevenne, D., Tiret, L., Czernichow, P., & Lévy‐Marchal, C. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3473 · Cited by 87
Diclofenac Antagonizes Peroxisome Proliferator-Activated Receptor-γ Signaling
Adamson, D. J. A., Frew, D., Tatoud, R., Wolf, C. R., & Palmer, C. N. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.7 · Cited by 85
Evolution of Insulin Resistance in New Zealand Obese Mice
Veroni, M., Proietto, J., & Larkins, R. G. (1991) · Diabetes · doi:10.2337/diab.40.11.1480 · Cited by 82
Chakrabarti, R., Vikramadithyan, R. K., Misra, P., Hiriyan, J., Raichur, S., Damarla, R. K. B., Gershome, C., Suresh, J., & Rajagopalan, R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705463 · Cited by 79
Yamamoto, Y., Hirose, H., Miyashita, K., Nishikai, K., Saito, I., Taniyama, M., Tomita, M., & Saruta, T. (2002) · Metabolism · doi:10.1053/meta.2002.35586 · Cited by 77
Wong, C.-W., & Privalsky, M. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5724 · Cited by 74
Bishop‐Bailey, D., & Warner, T. D. (2003) · The FASEB Journal · doi:10.1096/fj.02-1075fje · Cited by 73
Poulsen, P., Andersen, G., Fenger, M., Hansen, T. F., Echwald, S. M., Vølund, A., Beck‐Nielsen, H., Pedersen, O. B., & Vaag, A. A. (2003) · Diabetes · doi:10.2337/diabetes.52.1.194 · Cited by 70
Nakamura, Y., Ohya, Y., Onaka, U., Fujii, K., Abe, I., & Fujishima, M. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701669 · Cited by 67
PPARγ controls cell proliferation and apoptosis in an RB-dependent manner
Lluis Fajas, A., Egler, V., Reiter, R. J., Miard, S., Lefebvre, A., & Auwerx, J. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206530 · Cited by 67
Self-citationHYPERTENSION AND INSULIN RESISTANCE: ROLE OF PEROXISOME PROLIFERATOR‐ACTIVATED RECEPTOR γ
Itoh, H., Doi, K., Tanaka, T., Fukunaga, Y., Hosoda, K., Inoue, G., Nishimura, H., Yoshimasa, Y., Yamori, Y., & Nakao, K. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03082.x · Cited by 63
stgren, C. J., Lindblad, U., Melander, O., Melander, A., Groop, L., & stam, L. R. (2003) · Journal of Hypertension · doi:10.1097/00004872-200309000-00014 · Cited by 60
Misra, P., Chakrabarti, R., Vikramadithyan, R. K., Bulusu, G., Suresh, J., Hiriyan, J., Gershome, C., Rajjak, A., Kashireddy, P. V., Yu, S., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049791 · Cited by 59
Zhang, B., Szalkowski, D., Diaz, E., Hayes, D. N., Smith, R. G., & Berger, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47309-7 · Cited by 58
Östgren, C. J., Lindblad, U., Melander, O., Melander, A., Groop, L., & Råstam, L. (2003) · PubMed · doi:10.1097/01.hjh.0000084734.53355.0d · Cited by 56
Lei, H., Chen, M. H., Yang, W., Chiu, M. C., Chen, M. C., Tai, T. Y., & Chuang, L. (2000) · Metabolism · doi:10.1053/meta.2000.9517 · Cited by 54
Zietz, B., Barth, N., Spiegel, D. P., Schmitz, G., Schölmerich, J., & Schaeffler, A. (2002) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2002-23487 · Cited by 50
Pihlajamäki, J., Miettinen, R., Valve, R., Karjalainen, L., Mykkänen, L. M., Kuusisto, J., Deeb, S. S., Auwerx, J. H., & Laakso, M. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00433-5 · Cited by 50
Self-citationSchneider, J. G., Kreuzer, J., Hamann, A., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.3.867 · Cited by 50
Eriksson, J. G., Lindi, V., Uusitupa, M. I. J., Forsén, T., Laakso, M., Osmond, C., & Barker, D. J. P. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00150.x · Cited by 49
Miles, P. D. G., Barak, Y., Evans, R. M., & Olefsky, J. M. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00312.2002 · Cited by 49
Bruemmer, D., Berger, J. P., Liu, J., Kintscher, U., Wakino, S., Fleck, E., Moller, D. E., & Law, R. E. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01556-5 · Cited by 48
Smith, W. M., Zhou, X.-P., 黒瀬, 圭., Gao, X., Latif, F., Kroll, T. G., Sugano, K., Cannistra, S. A., Clinton, S. K., Maher, E. R., et al. (2001) · Human Genetics · doi:10.1007/s004390100563 · Cited by 46
Kolehmainen, M., Uusitupa, M. I. J., ALHAVA, E. M., Laakso, M., & Vidal, H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020603 · Cited by 44
Li, S., Chen, W., Srinivasan, S. R., Boerwinkle, E., & Berenson, G. S. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1265 · Cited by 44
Memisoglu, A., Hankinson, S. E., Manson, J. E., Colditz, G. A., & Hunter, D. J. (2002) · Pharmacogenetics · doi:10.1097/00008571-200211000-00003 · Cited by 43
Paltoo, D. N., Woodson, K. G., Taylor, P. R., Albanes, D., Virtamo, J. R. K., & Tangrea, J. A. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00617-1 · Cited by 41
A region on chromosome 3 is linked to dizygotic twinning
Busjahn, A., Knoblauch, H., Faulhaber, H., Aydın, A., Uhlmann, R., Tuomilehto, J., Kaprio, J. A., Jędrusik, P., Januszewicz, A., Strelau, J., et al. (2000) · Nature Genetics · doi:10.1038/82515 · Cited by 39
Vaccaro, O., Mancini, F. P., Ruffa, G., Sabatino, L., Iovine, C., Masulli, M., Colantuoni, V., & Riccardi, G. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01618.x · Cited by 36
Schäffler, A., Barth, N., Schmitz, G., Zietz, B., Palitzsch, K., & Schölmerich, J. (2001) · Endocrine · doi:10.1385/endo:14:3:369 · Cited by 35
Chromatin remodeling regulated by steroid and nuclear receptors
Wolffe, A. P. (1997) · Cell Research · doi:10.1038/cr.1997.14 · Cited by 34
Cited by
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0002 · Cited by 4,585
Bahn, R. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0905750 · Cited by 1,552
Manolagas, S. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0024 · Cited by 1,200
Disordered lipid metabolism and the pathogenesis of insulin resistance.
Savage, D. B., Petersen, K. F., & Shulman, G. I. (2007) · Physiological Reviews · doi:10.1152/physrev.00024.2006 · Cited by 1,107
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
Michalik, L., Auwerx, J., Berger, J. P., Chatterjee, V. K., Glass, C. K., Gonzalez, F. J., Grimaldi, P. A., Kadowaki, T., Lazar, M. A., O’Rahilly, S., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.5 · Cited by 1,000
Self-citation
Metadata
- Authors
- Knouff, C., & Auwerx, J.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-12-01
- Volume
- 25
- Issue
- 6
- Pages
- 899-918
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2058406367
- Cited by
- 256
- References
- 211
- FWCI
- 7.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.